Betaseron (interferon beta-1b) for Injection, for Subcutaneous Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
WARNINGS AND PRECAUTIONS
Drug-induced Lupus Erythematosus
Cases of drug-induced lupus erythematosus have been...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts